MOM to conduct more workplace inspections, advises firms to call for voluntary safety timeout
MOM to conduct more workplace inspections, advises firms to call for voluntary safety timeout
SINGAPORE - The Ministry of Manpower (MOM) will ramp up inspections in certain 'high-risk sectors' and is asking firms to carry out a voluntary safety timeout, after five workplace deaths were recorded in May.
The number of deaths was an increase from the t hree during the same period in 2024 , which showed the need for 'stronger ownership and accountability,' the ministry said in a Facebook post on June 11.
As a 'pre-emptive measure', it said it is calling on firms to conduct a voluntary safety timeout between June 12 and 26 , with an emphasis on vehicular safety, and work that takes place at height.
In doing so, MOM said that employers and workers can review safety procedures, reinforce controls and fix any problems identified, as well as solidify their commitment to safety .
It added that measures to lessen heat stress should also be put in place, as warmer weather is expected in June and July.
Besides the safety timeout, MOM also said it will increase its enforcement inspections by 25 per cent, focusing on high-risk sectors.
These include construction, manufacturing, marine, transportation and storage.
Workplaces found to have breached the rules can be issued a stop-work order or a fine, with some possibly facing prosecution under the Workplace Safety and Health Act.
The number of workplace deaths had climbed to 43 in 2024 after falling to 36 in 2023.
Vehicular incidents were the top cause of death, followed by suffocation or drowning, with the construction sector accounting for the most deaths, with 20 recorded.
Join ST's WhatsApp Channel and get the latest news and must-reads.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
2 minutes ago
- Straits Times
Serena Williams to promote weight-loss drugs with telehealth firm Ro
Sign up now: Get ST's newsletters delivered to your inbox FILE PHOTO: Sep 2, 2022; Flushing, NY, USA; Serena Williams of the United States hits to Ajla Tomljanovic of Australia on day five of the 2022 U.S. Open tennis tournament at USTA Billie Jean King Tennis Center. Mandatory Credit: Danielle Parhizkaran-USA TODAY Sports/File Photo Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss treatments, the company said Thursday. The 23-time Grand Slam champion, who retired from professional tennis in 2022, will headline a multi-year national marketing campaign for GLP-1 drugs, a company spokesperson said. "I don't take shortcuts," Williams said in an NBC News interview, adding that her efforts to lose weight before turning to GLP-1 treatments included professional tennis training. "I was doing everything right ... but my body wasn't responding the way it used to," she said. Williams said in an advertisement that after struggling to lose post-baby weight, the treatments helped her lose 31 pounds (14 kg) - her first time speaking out about using them, Ro said. "Serena knows people may be surprised to learn that she would use a GLP-1, and that's exactly why we think she is the perfect person to share her story," said a Ro spokesperson. Ro said Williams' husband Alexis Ohanian, the co-founder of social media site Reddit, is an investor in the company and serves on its board. Top stories Swipe. Select. Stay informed. Singapore Courier tip-off leads to HSA seizure of Kpods, drugs in Tampines and Grange Road raids Singapore Large flocks of parakeets a spectacle in Choa Chu Kang, but they may affect native species Singapore Singapore students shine in Paris with record medal haul at history Olympiad Singapore Teacher charged over allegedly making student undress in video call, sending her his nude photo Singapore Painting by police NSF presented to Shanmugam to commemorate 50 years of Police National Service Business 8 more active ETFs by JPMorgan Asset Management available to Singapore investors Business Changi Travel Services cuts 30 staff amid market shifts Asia HK water scandal: How distrust over China bottled water sparked a probe into govt contract GLP-1 drugs promote weight loss by reducing appetite and causing the stomach to empty more slowly. Novo Nordisk's Wegovy and Eli Lilly's Zepbound have been shown to reduce weight by around 20%. Ro, which sells both drugs through its weight-loss program, said Williams was on a branded GLP-1 but declined to say which one. Paul Cerro, a former Ro strategy analyst and founder of Cedar Grove Capital Management, said the deal will boost Ro's visibility and credibility in a crowded weight-loss drug market as companies push deeper into women's health. "Well known people are willing to put their name with a company that they believe is doing the right thing in the right way," said Cerro. Ro offers cash-pay access to Zepbound and Wegovy through Novo and Lilly's direct pharmacies, although eligible patients can use insurance. It sells compounded Wegovy in varying doses for patients whose clinicians deem it medically necessary. REUTERS
Straits Times
2 minutes ago
- Straits Times
Sweden picks mini-reactors for first nuclear expansion in 50 years
Sign up now: Get ST's newsletters delivered to your inbox Three or five of the next-generation SMR reactors will be built at the Ringhals plant in southwestern Sweden. STOCKHOLM - Sweden said on Aug 21 that it had selected so-called small modular nuclear reactors (SMRs) for its first nuclear power expansion in a half-century. The government said three or five of the next-generation reactors would be built at the Ringhals plant in southwestern Sweden, providing around 1,500 megawatts – the equivalent of two classic reactors. 'For the first time in 50 years, new nuclear power will be built in Sweden,' Prime Minister Ulf Kristersson told a press conference. The Scandinavian country voted in a non-binding 1980 referendum to phase out nuclear power, and since then has shut down six of its 12 ageing reactors. But a political majority is now in favour of extending nuclear power, along with renewable energy sources, to reduce its use of fossil fuels. Sweden's state energy utility Vattenfall, which had also been considering classic reactor technology, said either British group Rolls-Royce or American group GE Vernova would be selected as the supplier. Chief executive Anna Borg said the cost of the project 'was still a matter of negotiation', adding that Vattenfall aimed to have the new reactors built by around 2035. Top stories Swipe. Select. Stay informed. Singapore Courier tip-off leads to HSA seizure of Kpods, drugs in Tampines and Grange Road raids Singapore Large flocks of parakeets a spectacle in Choa Chu Kang, but they may affect native species Singapore Singapore students shine in Paris with record medal haul at history Olympiad Singapore Teacher charged over allegedly making student undress in video call, sending her his nude photo Singapore Painting by police NSF presented to Shanmugam to commemorate 50 years of Police National Service Business 8 more active ETFs by JPMorgan Asset Management available to Singapore investors Business Changi Travel Services cuts 30 staff amid market shifts Asia HK water scandal: How distrust over China bottled water sparked a probe into govt contract In addition, she said the company was 'already looking at the next step to build additional reactors where Ringhals 1 and 2 are currently located'. Sweden's six active reactors currently generate about 30 per cent of its electricity needs. SMRs are potentially relatively simple to build, making them more affordable than large power reactors. However, the technology is still experimental and only a handful of units have been built anywhere in the world. Environmental group Greenpeace criticised the right-wing government's plan as vague, citing the lack of a budget, timeline and construction permits. In a statement, it said the government was 'trying to trick the Swedish people into believing that new nuclear power would lead to cheap and green electricity'. 'New nuclear power will require some of the biggest state subsidies in Sweden's history, will increase emissions and delay the electrification of industry,' it said. AFP
Straits Times
31 minutes ago
- Straits Times
Telehealth firm Ro enlists Serena Williams to promote weight-loss drugs
Sign up now: Get ST's newsletters delivered to your inbox FILE PHOTO: Sep 2, 2022; Flushing, NY, USA; Serena Williams of the United States hits to Ajla Tomljanovic of Australia on day five of the 2022 U.S. Open tennis tournament at USTA Billie Jean King Tennis Center. Mandatory Credit: Danielle Parhizkaran-USA TODAY Sports/File Photo Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss treatments, the company said Thursday. The 23-time Grand Slam champion will headline a multi-year national marketing campaign for GLP-1 drugs, a company spokesperson said. Williams, who retired from professional tennis in 2022, said in an advertisement that after struggling to lose post-baby weight, the treatments helped her lose 31 pounds (14 kg) - her first time speaking out about using them, Ro said. "Serena knows people may be surprised to learn that she would use a GLP-1, and that's exactly why we think she is the perfect person to share her story," said a Ro spokesperson. Ro said Williams' husband Alexis Ohanian, the co-founder of social media site Reddit, is an investor in the company and serves on its board. GLP-1 drugs promote weight loss by reducing appetite and causing the stomach to empty more slowly. Novo Nordisk's Wegovy and Eli Lilly's Zepbound have been shown to reduce weight by around 20%. Ro, which sells both drugs through its weight-loss program, said Williams was on a branded GLP-1 but declined to say which one. Paul Cerro, a former Ro strategy analyst and founder of Cedar Grove Capital Management, said the deal will boost Ro's visibility and credibility in a crowded weight-loss drug market as companies push deeper into women's health. "Well known people are willing to put their name with a company that they believe is doing the right thing in the right way," said Cerro. Ro offers cash-pay access to Zepbound and Wegovy through Novo and Lilly's direct pharmacies, although eligible patients can use insurance. It sells compounded Wegovy in varying doses for patients whose clinicians deem it medically necessary. REUTERS
